The payment card technology provider, which counts Visa, CommerzBank, CreditEase and Mastercard as investors, has added about $190m to close its IPO.

Broad Institute and UPenn-linked cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.

GV and Novo-backed cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.

The solid-state battery maker will get a Nasdaq listing through the deal, which follows $161m in funding from investors including Ford, BMW, Sanoh, Hyundai, A123, Samsung and Solvay.

Tencent and Sunshine Life-backed recruitment app developer floated at the top of its range and has seen its share price more than double since.

American Airlines, Avolon, Honeywell, Rolls-Royce, 40 North and M12 have contributed to a private placement backing the transaction.

The application development software provider has closed its initial public offering, with Zoom and Salesforce having bought $150m of shares.

The Aeon and American Express-backed online grocery retailer is set to list its shares on the Nasdaq Capital Market through a reverse takeover.

The Alibaba Health-backed medical data technology and services provider has chosen the US for its planned initial public offering.

The pregnancy biomarker test provider plans to float on the Nasdaq Global Market having raised $220m in funding from investors including LabCorp and Anthem.